Table 2.
Summary of proportions of adverse outcomes reported for atovaquone-proguanil and proguanil.
| Summary of adverse outcomes by drug | ||||||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Atovaquone-Proguanil | Proguanil | |||||||
|
|
||||||||
| Miscarriage | Stillbirth | Early Death | Congenital Anomaly | Miscarriage | Stillbirth | Early Death | Congenital Anomaly | |
|
| ||||||||
| n/N Percentage (95% CI) | 21/260 8.08 (5.07, 12.08) | 1/95 1.05 (0.03, 5.73) | 0/48 0 (0, 7.4) | 11/430 2.56 (1.28, 4.53) | 23/907 2.53 (1.61, 3.78) | 2/427 0.47 (0.06, 1.68) | 31/515 6.02 (4.13, 8.43) | 15/331 4.53 (2.56, 7.36) |